
Sign up to save your podcasts
Or


In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, is joined by Ryan Svoboda, MD, for an in-depth review of cutaneous lymphomas.
They begin with a boards review of the four primary cutaneous B-cell lymphomas—two indolent (follicle center, marginal zone) and two aggressive (diffuse large B-cell, intravascular B-cell). The discussion covers prognostic differences, biopsy strategies, key immunostains, helpful mnemonics for BCL markers, and notable associations such as Borrelia infection.
In the main segment, the focus shifts to cutaneous T-cell lymphomas, particularly mycosis fungoides. Dr Svoboda shares diagnostic challenges, strategies to improve biopsy yield, and a practical scoring algorithm to interpret inconclusive pathology reports. They also review tips for diagnosing Sézary syndrome and highlight relevant NCCN guidelines.
Tune in to the full episode for high-yield insights on recognizing, diagnosing, and managing both B-cell and T-cell cutaneous lymphomas in clinical practice.
By Dermsquared5
66 ratings
In this episode of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, is joined by Ryan Svoboda, MD, for an in-depth review of cutaneous lymphomas.
They begin with a boards review of the four primary cutaneous B-cell lymphomas—two indolent (follicle center, marginal zone) and two aggressive (diffuse large B-cell, intravascular B-cell). The discussion covers prognostic differences, biopsy strategies, key immunostains, helpful mnemonics for BCL markers, and notable associations such as Borrelia infection.
In the main segment, the focus shifts to cutaneous T-cell lymphomas, particularly mycosis fungoides. Dr Svoboda shares diagnostic challenges, strategies to improve biopsy yield, and a practical scoring algorithm to interpret inconclusive pathology reports. They also review tips for diagnosing Sézary syndrome and highlight relevant NCCN guidelines.
Tune in to the full episode for high-yield insights on recognizing, diagnosing, and managing both B-cell and T-cell cutaneous lymphomas in clinical practice.

3,476 Listeners

2,439 Listeners

3,362 Listeners

56,575 Listeners

16 Listeners

165,492 Listeners

35 Listeners

383 Listeners

135 Listeners

6 Listeners

51 Listeners

19,851 Listeners

6 Listeners

3 Listeners

32 Listeners